EC’s OTC derivatives rules leave questions unanswered

Testing Esma


The long-awaited publication of proposed regulation on over-the-counter derivatives by the European Commission (EC) on September 15 was expected to be a landmark moment, but in the end it was more of a damp squib. Widely leaked in advance, the text contained few surprises and left some of the most important technical details to be determined further down the line by a new pan-European supervisory authority. As the text now passes to the European Parliament and European Union (EU) member states

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: